Your browser doesn't support javascript.
loading
Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry.
Li, Feng; Lai, Li; You, Zhijie; Cheng, Hui; Guo, Guodong; Tang, Chenchen; Xu, Luyun; Liu, Hongxia; Zhong, Wenting; Lin, Youyu; Wang, Qingshui; Lin, Yao; Wei, Yongbao.
Afiliación
  • Li F; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
  • Lai L; Department of Pathology, Fujian Provincial Hospital, Fuzhou, China.
  • You Z; The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Cheng H; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
  • Guo G; Central Laboratory, Fujian Provincial Hospital, Fuzhou, China.
  • Tang C; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
  • Xu L; Department of Pathology, Fujian Provincial Hospital, Fuzhou, China.
  • Liu H; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
  • Zhong W; Department of Pathology, Fujian Provincial Hospital, Fuzhou, China.
  • Lin Y; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
  • Wang Q; Department of Pathology, Fujian Provincial Hospital, Fuzhou, China.
  • Lin Y; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
  • Wei Y; The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Front Mol Biosci ; 9: 813428, 2022.
Article en En | MEDLINE | ID: mdl-35211510

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Front Mol Biosci Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Front Mol Biosci Año: 2022 Tipo del documento: Article País de afiliación: China